Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database

Treatment Patterns and Outcomes in Patients With Advanced Melanoma: A Retrospective Study Using Data From the German ADOREG Registry

This study is a non-interventional retrospective observational study performed on secondary data from a German multi-site cohort registry, the German national registry of skin cancer (ADOReg).

Inclusion Criteria:

• Signed informed consent for inclusion in ADOReg registry must be documented at study site
• Diagnosis of advanced (nonresectable or metastatic) melanoma in stage III or stage IV
• Participants received any systemic therapy to treat the advanced melanoma
• First-line systemic treatment was initiated within the index window (19-Jun-2015 to 30-Jun-2018)

Exclusion Criteria:

• Age <18 years at index date
• Receipt of clinical trial study drug at any time